Fritz Mary Beth's Form 4 filing
Prestige Consumer Healthcare Inc. (PBH) · filed Feb 29, 2024
- Accession no.
- 0001104659-24-029348
- Filed
- Feb 29, 2024
- Trade date
- Feb 27-28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $46.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fritz Mary BethCIK 0001749505 | Officer (SVP Quality & Regulatory) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +1 | $57.18 | +$57.18 | 15,935 | Direct | |
| Feb 27, 2024 | Common Stock, par value $0.01 per share | SSaleDisposed | −1 | $70.00 | −$70 | 15,934 | Direct | |
| Feb 28, 2024 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +246 | $57.18 | +$14,066.28 | 16,180 | Direct | |
| Feb 28, 2024 | Common Stock, par value $0.01 per share | SSaleDisposed | −246 | $70.19F1 | −$17,266.74 | 15,934 | Direct | |
| Feb 28, 2024 | Common Stock, par value $0.01 per share | MOption exerciseAcquired | +416 | $30.56 | +$12,712.96 | 16,350 | Direct | |
| Feb 28, 2024 | Common Stock, par value $0.01 per share | SSaleDisposed | −416 | $70.36F2 | −$29,269.76 | 15,934 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Common Stock | MOption exerciseDisposed | −1 | $0.00 | $0 | 308 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −246 | $0.00 | $0 | 62 | Direct | |
| Feb 28, 2024 | Common Stock | MOption exerciseDisposed | −416 | $0.00 | $0 | 110 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $70.03 to $70.19.
Referenced by the price of 1 transaction in Table I.
- F2
Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $70.06 to $70.36.
Referenced by the price of 1 transaction in Table I.